Literature DB >> 24531837

Recent developments in the role of high-mobility group box 1 in systemic lupus erythematosus.

Fleur Schaper1, Johanna Westra1, Marc Bijl2.   

Abstract

High-mobility group box 1 (HMGB1) is an important molecule for several nuclear processes. Recently, HMGB1 has gained much attention as a damage-associated molecular pattern (DAMP) and has been implicated in the pathogenesis of several (auto)-immune diseases, in particular, systemic lupus erythematosus (SLE). A main pathogenic feature in SLE is the accumulation of apoptotic cells. Since HMGB1 is released from apoptotic cells it has been hypothesized that HMGB1 might fuel the inflammatory processes, as seen in this disease, and play a fundamental role in the pathogenesis. In this review, we discuss evidence in support of the theory that HMGB1 is an important mediator in SLE and may be considered a new autoantigen.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24531837      PMCID: PMC3960395          DOI: 10.2119/molmed.2014.00019

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.354


  74 in total

1.  Serum HMGB1 levels are increased in active Wegener's granulomatosis and differentiate between active forms of ANCA-associated vasculitis.

Authors:  D Wibisono; E Csernok; P Lamprecht; J U Holle; W L Gross; F Moosig
Journal:  Ann Rheum Dis       Date:  2010-06-11       Impact factor: 19.103

2.  Src family kinases are necessary for cell migration induced by extracellular HMGB1.

Authors:  Roberta Palumbo; Francesco De Marchis; Tobias Pusterla; Antonio Conti; Massimo Alessio; Marco E Bianchi
Journal:  J Leukoc Biol       Date:  2009-04-28       Impact factor: 4.962

3.  The alarmin HMGB1 acts in synergy with endogenous and exogenous danger signals to promote inflammation.

Authors:  Hulda Sigridur Hreggvidsdottir; Therese Ostberg; Heidi Wähämaa; Hanna Schierbeck; Ann-Charlotte Aveberger; Lena Klevenvall; Karin Palmblad; Lars Ottosson; Ulf Andersson; Helena Erlandsson Harris
Journal:  J Leukoc Biol       Date:  2009-06-29       Impact factor: 4.962

4.  The C-terminal acidic tail is responsible for the inhibitory effects of HMGB1 on efferocytosis.

Authors:  Sami Banerjee; Arnaud Friggeri; Gang Liu; Edward Abraham
Journal:  J Leukoc Biol       Date:  2010-08-03       Impact factor: 4.962

5.  A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release.

Authors:  Huan Yang; Hulda S Hreggvidsdottir; Karin Palmblad; Haichao Wang; Mahendar Ochani; Jianhua Li; Ben Lu; Sangeeta Chavan; Mauricio Rosas-Ballina; Yousef Al-Abed; Shizuo Akira; Angelika Bierhaus; Helena Erlandsson-Harris; Ulf Andersson; Kevin J Tracey
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-14       Impact factor: 11.205

6.  Expression of high mobility group box chromosomal protein 1 and its modulating effects on downstream cytokines in systemic lupus erythematosus.

Authors:  Jie Li; Hongfu Xie; Ting Wen; Hongbo Liu; Wu Zhu; Xiang Chen
Journal:  J Rheumatol       Date:  2010-01-28       Impact factor: 4.666

7.  High-mobility group box-1 protein (HMGB1) is increased in antineutrophilic cytoplasmatic antibody (ANCA)-associated vasculitis with renal manifestations.

Authors:  Annette Bruchfeld; Mårten Wendt; Johan Bratt; Abdul R Qureshi; Sangeeta Chavan; Kevin J Tracey; Karin Palmblad; Iva Gunnarsson
Journal:  Mol Med       Date:  2010-09-10       Impact factor: 6.354

8.  HMGB1 inhibits macrophage activity in efferocytosis through binding to the alphavbeta3-integrin.

Authors:  Arnaud Friggeri; Yanping Yang; Sami Banerjee; Yong-Jun Park; Gang Liu; Edward Abraham
Journal:  Am J Physiol Cell Physiol       Date:  2010-09-08       Impact factor: 4.249

9.  Oxidation of the alarmin high-mobility group box 1 protein (HMGB1) during apoptosis.

Authors:  Vilma Urbonaviciute; Silke Meister; Barbara G Fürnrohr; Benjamin Frey; Eva Gückel; Georg Schett; Martin Herrmann; Reinhard E Voll
Journal:  Autoimmunity       Date:  2009-05       Impact factor: 2.815

10.  Neutrophil extracellular traps: how to generate and visualize them.

Authors:  Volker Brinkmann; Britta Laube; Ulrike Abu Abed; Christian Goosmann; Arturo Zychlinsky
Journal:  J Vis Exp       Date:  2010-02-24       Impact factor: 1.355

View more
  18 in total

1.  Endotoxin tolerance in monocytes can be mitigated by α2-interferon.

Authors:  Lihua Shi; Li Song; Kelly Maurer; James Sharp; Zhe Zhang; Kathleen E Sullivan
Journal:  J Leukoc Biol       Date:  2015-07-23       Impact factor: 4.962

Review 2.  The Role of Damage-Associated Molecular Patterns in Human Diseases: Part I - Promoting inflammation and immunity.

Authors:  Walter G Land
Journal:  Sultan Qaboos Univ Med J       Date:  2015-01-21

Review 3.  Molecular mechanism and therapeutic modulation of high mobility group box 1 release and action: an updated review.

Authors:  Ben Lu; Ce Wang; Mao Wang; Wei Li; Fangping Chen; Kevin J Tracey; Haichao Wang
Journal:  Expert Rev Clin Immunol       Date:  2014-04-19       Impact factor: 4.473

Review 4.  HMGB1 in health and disease.

Authors:  Rui Kang; Ruochan Chen; Qiuhong Zhang; Wen Hou; Sha Wu; Lizhi Cao; Jin Huang; Yan Yu; Xue-Gong Fan; Zhengwen Yan; Xiaofang Sun; Haichao Wang; Qingde Wang; Allan Tsung; Timothy R Billiar; Herbert J Zeh; Michael T Lotze; Daolin Tang
Journal:  Mol Aspects Med       Date:  2014-07-08

5.  C1q and HMGB1 reciprocally regulate human macrophage polarization.

Authors:  Myoungsun Son; Amit Porat; Mingzhu He; Jolien Suurmond; Frances Santiago-Schwarz; Ulf Andersson; Thomas R Coleman; Bruce T Volpe; Kevin J Tracey; Yousef Al-Abed; Betty Diamond
Journal:  Blood       Date:  2016-09-28       Impact factor: 22.113

6.  Expression of HMGB1/RAGE protein in renal carcinoma and its clinical significance.

Authors:  Guo-Qiang Qie; Chun-Ting Wang; Yu-Feng Chu; Rong Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

Review 7.  The Effect and Regulatory Mechanism of High Mobility Group Box-1 Protein on Immune Cells in Inflammatory Diseases.

Authors:  Yun Ge; Man Huang; Yong-Ming Yao
Journal:  Cells       Date:  2021-04-28       Impact factor: 6.600

Review 8.  The Potential Role of Ferroptosis in Systemic Lupus Erythematosus.

Authors:  Qian Chen; Jie Wang; Mengmeng Xiang; Yilun Wang; Zhixiong Zhang; Jun Liang; Jinhua Xu
Journal:  Front Immunol       Date:  2022-04-21       Impact factor: 8.786

9.  The presence of high mobility group box-1 and soluble receptor for advanced glycation end-products in juvenile idiopathic arthritis and juvenile systemic lupus erythematosus.

Authors:  Dubravka Bobek; Danka Grčević; Nataša Kovačić; Ivan Krešimir Lukić; Marija Jelušić
Journal:  Pediatr Rheumatol Online J       Date:  2014-12-03       Impact factor: 3.054

10.  Antibodies against High Mobility Group Box protein-1 (HMGB1) versus other anti-nuclear antibody fine-specificities and disease activity in systemic lupus erythematosus.

Authors:  Lina Wirestam; Hanna Schierbeck; Thomas Skogh; Iva Gunnarsson; Lars Ottosson; Helena Erlandsson-Harris; Jonas Wetterö; Christopher Sjöwall
Journal:  Arthritis Res Ther       Date:  2015-11-23       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.